Pfizer, a global biopharmaceutical company headquartered in New York City, employs 88,000 people and focuses on discovering, developing, and distributing oncology, primary care, and specialty care products worldwide. Key products include Ibrance, Eliquis, and Xeljanz, among others.
PFE has been in the news recently: PFIZER is not directly mentioned in the provided information, but it is important to note that the pharmaceutical industry is facing advancements and challenges, as seen with BioNTech's focus on enhancing patient and shareholder value. Additionally, GSK's FDA approval of leucovorin represents a significant development in treatment options for rare genetic disorders.
📡️ Health Care
In The News
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.